The Best AI Show on Pharma

Ayush Mishra

In a world where healthcare decisions are getting faster, smarter, and more complex, one force is quietly reshaping the entire pharma landscape: intelligence. Not the kind you read in reports, but the kind that emerges when data, science, and experience collide. The Best AI Show on Pharma steps right into that intersection. Hosted by Ayush Mishra, this podcast brings you candid, future-facing conversations with leaders who are redefining how medicines are discovered, developed, and delivered. Each episode goes beyond buzzwords, beyond hype, and beyond surface-level talk. These are the real stories, the challenges no one admits, the breakthroughs no one sees coming, and the visions shaping the next decade of medicine. Whether you are a pharma professional, a healthcare innovator, or someone who believes that smarter technology can lead to better outcomes, this is where the future becomes understandable, practical, and actionable.

Episodes

  1. Ep #4 | Accelerating Clinical Trials with Real-World Data, Know What Actually Works with Ayush Mishra and Chandi Kodthiwada

    JAN 19

    Ep #4 | Accelerating Clinical Trials with Real-World Data, Know What Actually Works with Ayush Mishra and Chandi Kodthiwada

    The pharmaceutical industry doesn’t struggle with scientific innovation, it struggles with execution. Feasibility, enrollment, evidence generation, and regulatory confidence remain the biggest constraints on getting medicines to patients faster. In this episode of The Best AI Show on Pharma, Ayush Mishra speaks with Chandi Kodthiwada, Vice President, Product Management, Komodo Health, whose work sits at the intersection of real-world data, clinical development, and AI strategy across the life sciences ecosystem. While for more than a decade building data products for biopharma, Chandi explains why most AI initiatives stall, why clinical trial operations remain deeply inefficient, and why real-world evidence is becoming a strategic lever rather than a research afterthought. From feasibility to enrollment to post-market monitoring, we explore how data is reshaping drug development and where the industry is actually seeing ROI. This is not a futurist conversation, it’s a grounded look at what’s working today, what still breaks, and what needs to change for AI to truly matter in biopharma. Also get ready to know some deets on the recent partnership that happened between Komodo Health and Anervea. What You’ll Learn in This Episode: • Why AI pilots struggle inside pharma organizations  • Why 30% of clinical trial sites never enroll a patient  • Recent partnership that happened between Komodo Health and Anervea  • Why RWE is gaining regulatory traction beyond publications  • Why consulting isn’t going away, but the slide work is  • Why trial bottlenecks are now operational, not scientific  • Why structured context beats model complexity in real use cases  • Why execution is the new competitive edge in drug development  • Why startups need ecosystem fluency, not just technology If you’re involved in clinical development, RWE, regulatory, digital, medical, or commercial strategy, this episode offers a clear lens into where the industry is headed, and what’s required to get there. Connect with Ayush Mishra https://www.linkedin.com/in/ayushmishra/  Connect with Chandi Kotriwada https://www.linkedin.com/in/chandikodthiwada/ Watch on YouTube https://youtu.be/XIHNrAbE5N4  Watch Now on YouTube

    40 min
  2. Ep #3 | Beyond the AI Hype: Real Solutions for Clinical Trial Efficiency with Ayush Mishra and Suzanne Vyvoda

    JAN 14

    Ep #3 | Beyond the AI Hype: Real Solutions for Clinical Trial Efficiency with Ayush Mishra and Suzanne Vyvoda

    Clinical trials don’t fail because of bad science, they fail because the operations behind them are broken. In this high-signal episode, Ayush Mishra sits down with Suzanne Vyvoda, a 20-year clinical operations veteran who has built teams across 40+ countries, scaled billion-dollar trials, advised CROs, biotech founders, and helped companies cut trial costs by up to 25% without compromising quality. From the chaos inside clinical sites and the “Excel tracker economy” that still runs global trials to the quiet operational failures that delay drugs, inflate budgets, and frustrate stakeholders, Suzanne breaks down what really drives clinical trial inefficiency, and why AI alone won’t fix it. But this isn’t a pessimistic take. We unpack where AI is actually working, which use cases offer real ROI today, why RWE is becoming operationally strategic, and why the future of drug development won’t be about replacing people, but augmenting them. In This Episode, You’ll Learn: Why clinical trials are still powered by spreadsheets and PDFsWhy sites, CROs, and biotechs are all frustrated, and all correctWhy tech adoption fails when it adds work instead of removing itWhy RWE + site intelligence is the next frontier of feasibilityHow good contract design alone can cut trial costs dramaticallyWhy “ecosystem fluency” is the missing skill for AI foundersWhy CROs fear tech, and why that incentive structure needs to changeWhy the right MVP solves one problem, not 27Why the next wave of tools must feel native to real operatorsIf you want a real look at how trials actually run, from budget to operations to site burden to CRO incentives, and clarity on where AI fits (and doesn’t), this episode is unmissable. Watch till the end. Your understanding of clinical operations will change. Connect with Ayush Mishra https://www.linkedin.com/in/ayushmishra/  Connect with Suzanne Vyvoda https://www.linkedin.com/in/suzanne-vyvoda/ Watch on YouTube https://youtu.be/dalypa2iYi0  Watch Now on YouTube

    1h 8m
  3. Ep #2 | What’s Broken in American Healthcare and What the Future Holds with Ayush Mishra Ft. Dr. Marschall S. Runge

    12/16/2025

    Ep #2 | What’s Broken in American Healthcare and What the Future Holds with Ayush Mishra Ft. Dr. Marschall S. Runge

    America spends more on healthcare than any country on Earth, so why are they ranked 60th in healthy life expectancy? In this eye-opening episode, Ayush Mishra sits down with Dr. Marschall Runge, cardiologist, researcher, long-time CEO of Michigan Medicine, and author of The Great Healthcare Disruption, to unpack one of the biggest paradoxes in modern medicine. From the rise of chronic disease and the collapse of preventive care to the shocking inefficiencies buried inside the U.S. healthcare system, Dr. Runge breaks down what’s really driving America's poor outcomes and why critical care is world-class while the rest of healthcare continues to fall behind. But this conversation isn’t doom and gloom.  We dig into where AI is already transforming care, how predictive analytics will rewrite diagnosis and treatment, why smartwatches are saving more lives than ever, and why Big Tech (Amazon, Google) and pharma giants (like Eli Lilly) are redefining the future of medicine. You’ll also hear: Why academic medical centers must evolve or risk irrelevanceHow AI assistants will revolutionize chronic disease managementWhy preventive care is the REAL magic button to fix healthcareThe danger zones of AI and what must never be automatedWhether AI will reduce or widen the affordability gap If you want clarity on where American healthcare is headed and why the next decade will reshape medicine more than the last 100 years this episode is unmissable. Watch till the end. Your understanding of healthcare will change. Connect with Ayush Mishra: https://www.linkedin.com/in/ayushmishra/ Connect with Dr. Marschall S. Runge: https://www.linkedin.com/in/marschallsrunge/ Watch Now on YouTube

    1h 1m

About

In a world where healthcare decisions are getting faster, smarter, and more complex, one force is quietly reshaping the entire pharma landscape: intelligence. Not the kind you read in reports, but the kind that emerges when data, science, and experience collide. The Best AI Show on Pharma steps right into that intersection. Hosted by Ayush Mishra, this podcast brings you candid, future-facing conversations with leaders who are redefining how medicines are discovered, developed, and delivered. Each episode goes beyond buzzwords, beyond hype, and beyond surface-level talk. These are the real stories, the challenges no one admits, the breakthroughs no one sees coming, and the visions shaping the next decade of medicine. Whether you are a pharma professional, a healthcare innovator, or someone who believes that smarter technology can lead to better outcomes, this is where the future becomes understandable, practical, and actionable.